Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Immunology|December 26, 2001
Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activationRita Campanelli, Belinda Palermo, Silvia Garbelli, et al.
Methods in Cell Biology|February 13, 2026
Methodological advances to analyze cancer-associated fibroblast-derived ECM effects on macrophage polarizationAnnalisa Tocci, Lorenzo Valenti, Nicla Porciello, et al.
Oncoimmunology|July 29, 2016
Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOSOrnella Franzese, Belinda Palermo, Cosmo Di Donna, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
Dominant TCR-alpha requirements for a self antigen recognition in humansStefania Mantovani, Belinda Palermo, Silvia Garbelli, et al.
Oncoimmunology|June 25, 2024
ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICBOrnella Franzese, Belinda Palermo, Giuseppe Frisullo, et al.
European Journal of Immunology|October 15, 2005
Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligoBelinda Palermo, Silvia Garbelli, Stefania Mantovani, et al.
Oncoimmunology|February 17, 2023
Stereotactic Ablative Radiation Therapy in 3 Fractions Induces a Favorable Systemic Immune Cell Profiling in Prostate Cancer PatientsBelinda Palermo, Marta Bottero, Mariangela Panetta, et al.
The Journal of Investigative Dermatology|July 26, 2003
Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte-specific CD8+ T cells in one vitiligo patientStefania Mantovani, Silvia Garbelli, Belinda Palermo, et al.
Oncoimmunology|December 8, 2018
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patientsBelinda Palermo, Ornella Franzese, Cosmo Di Donna, et al.
Frontiers in Oncology|June 5, 2023
Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alphaFederica Moschella, Carla Buccione, Irene Ruspantini, et al.
Pageof 4